Skip to content
Screener

Onto Innovation ONTO Business Segments — Sales And Marketing Excluding12

Similar metrics at other companies

Theravance Biopharma logo
TBPHSingle Reportable — Sales & Marketing
$6.91M-5.4%
Research Solutions logo
RSSSSingle Reportable — Sales & Marketing
$1.51M-6.1%
908 Devices logo
MASSSingle Reportable — Sales & Marketing
$4.27M-12.5%
SES AI logo
SESSingle Reportable — Sales & Marketing
$497K+166%
Merit Medical Systems logo
MMSISingle Reportable — Sales & Marketing
$73.96M+13.9%
Vertex, Inc. logo
VERXSingle Reportable — Sales & Marketing
$52.64M+9.3%

Other financials

Income statement

See full
Revenue$343.1M+35.3%
Gross profit$183.3M+50.1%
Operating income$63.6M+97.1%
Net income$60.1M+75.8%
EPS (diluted)$1.21+75.4%

Balance sheet

See full
Cash & equivalents$1.3B+476%
Total debt$17.5M+15.3%
Total equity$1.9B-2.1%
Total assets$3.7B+72.8%

Cash flow

See full
Operating cash flow$61.5M+6.2%
CapEx$3.7M-73.4%
Free cash flow$57.9M+31.0%

Valuation

See full
Market cap$13.73B+212%
P/E84.6×+58.6×
P/S12.3×+8.0×

Profitability

See full
Gross margin50.4%-1.2pp
Operating margin12%-6.4pp
Net margin14.5%-1.8pp
FCF margin22.5%-0.5pp

Returns & leverage

See full
Return on equity8.3%-0.6pp
Debt / equity0.0×
Current ratio9.7×+0.1×

Where this comes from

Reported directly by Onto Innovation in its filing.

Tagged under the XBRL concept onto:SalesAndMarketingExcluding12.

The source filing: Onto Innovation’s 10-K, filed February 24, 2026.

Filed
Feb 24, 2026, 4:04 PM EST
Fiscal year
FY2025
Accession
0001193125-26-066937
Line itemYear Ended / January 3,2026Year Ended / December 28,2024Year Ended / December 30,2023
Less:
Adjusted cost of revenue (1)456,578457,855388,429
Adjusted research and development (2)132,668109,572103,656
Adjusted sales and marketing (2)69,95575,91061,604
Adjusted general and administrative (3)90,73676,68766,735
Other segment items:
Restructuring and other (4)63,38923,07710,599
Merger and acquisitions related (4)19,6017,6532,607

Item 16. Form 10-K Summary.

FAQ

What is Onto Innovation's business segments — sales and marketing excluding12?
Onto Innovation (ONTO) reported business segments — sales and marketing excluding12 of $17.49M in Q4 2025.
How has Onto Innovation's business segments — sales and marketing excluding12 changed year-over-year?
Onto Innovation's business segments — sales and marketing excluding12 decreased by 7.8% year-over-year, from $18.98M to $17.49M.
What is the long-term trend for Onto Innovation's business segments — sales and marketing excluding12?
Over 3 years (2022 to 2025), Onto Innovation's business segments — sales and marketing excluding12 has grown at a 2.2% compound annual growth rate (CAGR), from $65.56M to $69.96M.
What does business segments — sales and marketing excluding12 mean?
Represents the costs associated with promoting, selling, and distributing the company's systems to global microelectronics manufacturers. It measures the efficiency of the company's go-to-market strategy and customer acquisition efforts.

Ask your AI about Onto Innovation's business segments — sales and marketing excluding12.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude